一、引言:治疗抗药性抑郁症的挑战与机遇 抗药性抑郁症(treatment-resistant depression, TRD)是指那些对至少两种标准抗抑郁药物治疗无效的患者,通常表现出严重的抑郁症状和自杀倾向。这种情况在美国心理健康领域中显得尤为重要,因为大约40%的抑郁症患者被归类为抗药性抑郁症,面临着极其有限的治疗选择和长期的痛苦。传统的...
Esketamine nasal spray for treatment-resistant depression 发布机构: 英国国家卫生与临床优化研究所 发布日期: 2022-12-14 简要介绍: 关于esketamine (Spravato) 治疗成人难治性抑郁症的循证建议。 NICE的抑郁症指南还包括认知行为疗法(CBT)...
SPRAVATO® is an FDA-approved esketamine nasal spray, a refined form of ketamine, used to treat adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. It is also covered by most major insurances. Unlike...
Esketamine is the S-enantiomer of ketamine and has recently been FDA approved in the United States for treating depression that has failed to respond to trials of two or more antidepressants. Areas covered: This review will briefly discuss current treatment options for TRD, then review esketamine....
SPRAVATO® is an FDA-approved esketamine nasal spray, a refined form of ketamine, used to treat adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. It is also covered by most major insurances. Unlike...
SPRAVATO® is an FDA-approved esketamine nasal spray, a refined form of ketamine, used to treat adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. It is also covered by most major insurances. ...
SPRAVATO® is an FDA-approved esketamine nasal spray, a refined form of ketamine, used to treat adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. It is also covered by most major insurances. ...
强生旗下的杨森(Janssen)公司近日公开了两项针对治疗抵抗性(treatment resistant)抑郁症患者的积极结果,这项在研复方esketamine鼻腔喷雾剂的3期临床研究达到了主要疗效终点。研究结果将于近期在纽约举行的美国精神病学协会(American Psychiatric Association)年会上公开。
SPRAVATO® is an FDA-approved esketamine nasal spray, a refined form of ketamine, used to treat adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. It is also covered by most major insurances. ...
Spravato is a prescription medication for Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD) with Suicidal Ideation.Spravato (Esketamine) Treatment We Are A Janssen Certified Spravato Treatment Center SPRAVATO™ is an FDA approved prescription medicine, used with oral antidepressa...